PubMed , European Journal of Clinical Pharmacology , vol
Key Facts Originally launched in 2022, UPDATE uses paraxanthine, the compound the human body naturally forms from caffeine, rather than caffeine itself, an approach the company says eliminates the crash, jitters, and overstimulation of traditional energy drinks
Todays decision by the FDA offers hope for the millions of adults living with both conditions and provides an additional treatment option, representing a significant advancement for my patients. The FDA initially approved Ozempic in 2017 to improve blood sugar (glucose), along with diet and exercise, in adults with type 2 diabetes
Whitney Linsenmeyer, PhD, RD, Assistant Professor of Nutrition and Dietetics Reduced Appetite Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, meaning it mimics the effects of GLP-1, a naturally occurring hormone which activates GLP-1 receptors that are found throughout the pancreas, gastrointestinal tract, and brain